New Zealand markets closed

NVS Oct 2022 70.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.12000.0000 (0.00%)
At close: 10:33AM EDT
Full screen
Previous close1.1200
Open1.1200
Bid0.4500
Ask0.9000
Strike70.00
Expiry date2022-10-21
Day's range1.1200 - 1.1200
Contract rangeN/A
Volume1
Open interest12
  • Zacks

    Novartis (NVS) Announces Positive Data on Oncology Drug

    Novartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall survival in first-line advanced esophageal cancer combined with chemotherapy.

  • Zacks

    The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J

    Sanofi, Merck, Novartis, Pfizer and J&J are part of Zacks top Analyst Blog.

  • Bloomberg

    Novartis Leaning Toward Spinoff of $25 Billion Generics Arm

    (Bloomberg) -- Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale to private equity more difficult, people familiar with the matter said. Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesCrypto Meltdown Claims Rolex and Patek Philippe as VictimsStock Doomsayers Vindicated in Historic First Half: Markets WrapUkraine Latest: Kyiv La